Clinical studies

The goal of clinical studies is to evaluate and introduce new treatment of cancer. The clinical trial are conducted in the frame or under auspicies of international association, or as an EU funded projects, sponsored by pharmaceutical companies or are the results of our own knowledge.

Breast cancer

Code	Title	Principal Investigator at the Insitute of Oncology
EUROPA	Exclusive endocrine therapy or radiation therapy for women aged ≥70 years with luminal A-like early stage breast cancer (EUROPA): a randomised phase 3 trial	Ivica Ratosa
PALMIRA	International, multicenter, randomized, open-label, phase II clinical trial to evaluate the efficacy and safety of continuation of palbociclib	Erika Matos
LIDERA	A phase III, randomized, open-label, multicenter study evaluating the efficacy and safety of adjuvant giredestrant	Simona Borstnar
IMMUNOBREAST	The use of autologous immunohybridomas in treatment of patients with stage ii and III triple negative breast cancer	Simona Borstnar
KATE3	A randomized, multicenter, double-blind, placebo-contolled phase III study of the efficacy and safety of trastumab emtasine in combination with atezolizumab or placebo	Domen Ribnikar

Respiratory cancers

Code	Title	Principal Investigator at the Insitute of Oncology
ASTRES	A phase II, single-arm study of atezolizumab in patients with locally advanced, unresectable stage III non[1]small cell lung cancer who have not progressed after platinum-based concurrent chemoradiation	Martina Vrankar
TRacKING	Real world European registry of NTRK fusions and other rare actionable fusions	Mojca Unk
IMreal	A non-interventional, multicenter, multiple cohort study investigating the outcomes and safety of Atezolizumab under real-world conditions in patients treated in routine clinical practice (MO40653)	Nina Turnšek
AGILI	Cisplatin with either alimta or gemcitabine in long infusion for mesothelioma: a randomised phase II trial	Viljem Kovač

Gastrointestinal cancer

Code	Title	Principal Investigator at the Insitute of Oncology
PROMETCO	A Real World Evidence Prospective Cohort Study in the Management of Metastatic Colorectal Cancer: A Clinical and Patient Perspective	Janja Ocvirk
PREPARE	PREemptive Pharmacogenomic testing for Preventing Adverse drug REactions	Danijela Štrbac

Skin cancers

Code	Title	Principal Investigator at the Insitute of Oncology
MelMarT	Melanoma Margins Trial (MelMarT) Phase III, multi-centre, multi-national randomised control trial investigating 1 cm v 2 cm wide excision margins for primary cutaneous melanoma	Barbara Peric

Urinary tract cancer

Code	Title	Principal Investigator at the Insitute of Oncology
/	Treatment of radiation induced side effects with hyperbaric oxygen therapy	Helena Barbara Zobec Logar

Gynecological cancer

Code	Title	Principal Investigator at the Insitute of Oncology
/	Use of electrochemotherapy in women with vulvar cancer	Gregor Vivod
/	Individual approach in gynecological cancer brachytherapy	Helena Barbara Zobec Logar
/	The role of citopathology to define morphologic, antigen and molecular characteristics of epithelial ovarian cancer for determining diagnosis, treatment options and evaluation of immune response	Erik Škof

Head and neck cancers

No news available.

Name	Purpose	Lifetime
_pk_id	Counting web site visitors.	13 months
_pk_ref	Tracking from which sites users come to our web pages.	6 months
_pk_ses	Counting web site visits.	30 minutes
_ga	Used to distinguish users.	2 years
_ga_--container-id--	Persists session state.	2 years

Programs, Projects and Studies